TrialBMJ open2022

Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults.

Minoo Mohraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.